Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
6.26
-0.11 (-1.73%)
Jan 15, 2026, 4:00 PM EST - Market closed
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $203.59 million as of January 15, 2026. Its market cap has increased by 28.00% in one year.
Market Cap
203.59M
Enterprise Value
78.20M
1-Year Change
28.00%
Ranking
Category
Stock Price
$6.26
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $203.59M, a decrease of -42.62%. That is a compound annual growth rate of -19.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 207.16M | 7.60% |
| Dec 31, 2025 | 192.53M | 32.89% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
| Jul 14, 2023 | 354.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.49B |
| Johnson & Johnson | 514.75B |
| AbbVie | 390.15B |
| UnitedHealth Group | 302.49B |
| AstraZeneca | 291.77B |
| Novartis AG | 272.12B |
| Merck & Co. | 268.70B |
| Novo Nordisk | 265.30B |